KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Inventory Average (2023 - 2025)

Biocryst Pharmaceuticals' Inventory Average history spans 5 years, with the latest figure at $5.3 million for Q4 2025.

  • For Q4 2025, Inventory Average fell 32.07% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, down 32.07%, while the annual FY2025 figure was $6.7 million, 63.33% down from the prior year.
  • Inventory Average reached $5.3 million in Q4 2025 per BCRX's latest filing, up from $5.1 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $29.2 million in Q1 2024 to a low of $5.1 million in Q3 2025.
  • Average Inventory Average over 3 years is $15.3 million, with a median of $7.8 million recorded in 2024.
  • Peak YoY movement for Inventory Average: plummeted 78.8% in 2024, then fell 14.45% in 2025.
  • A 3-year view of Inventory Average shows it stood at $29.2 million in 2023, then crashed by 73.16% to $7.8 million in 2024, then plummeted by 32.07% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for BCRX's Inventory Average are $5.3 million (Q4 2025), $5.1 million (Q3 2025), and $6.0 million (Q2 2025).